Kornelia Aigner

642 total citations
29 papers, 385 citations indexed

About

Kornelia Aigner is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Kornelia Aigner has authored 29 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 11 papers in Surgery and 10 papers in Oncology. Recurrent topics in Kornelia Aigner's work include Renal cell carcinoma treatment (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Intraperitoneal and Appendiceal Malignancies (3 papers). Kornelia Aigner is often cited by papers focused on Renal cell carcinoma treatment (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Intraperitoneal and Appendiceal Malignancies (3 papers). Kornelia Aigner collaborates with scholars based in Germany, United States and Austria. Kornelia Aigner's co-authors include Kathleen D. Danenberg, Thomas Stadlbauer, T. Horikoshi, Bengt Gustavsson, Lawrence Leichman, Matthias Volkenandt, Roland Frösing, H. Breithaupt, Sandra L. Kopp and Karl Reinhard Aigner and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Cancers.

In The Last Decade

Kornelia Aigner

22 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kornelia Aigner Germany 8 169 158 82 71 48 29 385
Yuji Bessho Japan 7 270 1.6× 186 1.2× 90 1.1× 62 0.9× 37 0.8× 13 386
Semyon A. Risin United States 9 217 1.3× 203 1.3× 99 1.2× 57 0.8× 55 1.1× 25 564
K Csóka Sweden 12 207 1.2× 246 1.6× 47 0.6× 51 0.7× 23 0.5× 19 503
Shinji Endo Japan 12 130 0.8× 109 0.7× 96 1.2× 93 1.3× 39 0.8× 28 350
Ashwini Esnakula United States 13 174 1.0× 158 1.0× 79 1.0× 124 1.7× 47 1.0× 52 446
Satoshi Ohno Japan 12 105 0.6× 260 1.6× 111 1.4× 100 1.4× 39 0.8× 24 522
Robert L. Ruxer United States 10 178 1.1× 162 1.0× 129 1.6× 23 0.3× 27 0.6× 13 352
D. Wouters Netherlands 9 262 1.6× 226 1.4× 81 1.0× 33 0.5× 20 0.4× 13 472
Kotaro Shibahara Japan 12 129 0.8× 291 1.8× 121 1.5× 118 1.7× 19 0.4× 23 515
C. Tolis Greece 7 267 1.6× 207 1.3× 66 0.8× 41 0.6× 17 0.4× 13 429

Countries citing papers authored by Kornelia Aigner

Since Specialization
Citations

This map shows the geographic impact of Kornelia Aigner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kornelia Aigner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kornelia Aigner more than expected).

Fields of papers citing papers by Kornelia Aigner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kornelia Aigner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kornelia Aigner. The network helps show where Kornelia Aigner may publish in the future.

Co-authorship network of co-authors of Kornelia Aigner

This figure shows the co-authorship network connecting the top 25 collaborators of Kornelia Aigner. A scholar is included among the top collaborators of Kornelia Aigner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kornelia Aigner. Kornelia Aigner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Aigner, Kornelia, et al.. (2023). Case report. International Journal of Surgery Case Reports. 104(C). 107918–107918.
3.
Aigner, Karl Reinhard, et al.. (2021). Hypoxic isolated abdominal perfusion breaks through chemoresistance in recurrent FIGO stage IIIC and IV ovarian cancer. Molecular and Clinical Oncology. 14(6). 129–129. 2 indexed citations
4.
Aigner, Kornelia, et al.. (2021). Efficacy of Regional Chemotherapy Approach in Peritoneal Metastatic Gastric Cancer. Journal of Clinical Medicine. 10(22). 5322–5322. 3 indexed citations
5.
Aigner, Karl Reinhard, et al.. (2020). Approaching 10 years disease-free survival after isolated thoracic perfusion for advanced stage IV tonsil carcinoma. International Journal of Surgery Case Reports. 75(C). 71–74.
6.
Guadagni, Stefano, et al.. (2020). Multidisciplinary palliative treatment including isolated thoracic perfusion for progressive malignant pleural mesothelioma: a retrospective observational study.. PubMed. 24(3). 1259–1267. 1 indexed citations
7.
Aigner, Karl Reinhard, et al.. (2020). Survival and quality of life after isolated upper abdominal perfusion with chemofiltration (UAP-F) for stage III and IV pancreatic cancer.. Journal of Clinical Oncology. 38(4_suppl). 681–681. 1 indexed citations
8.
9.
Aigner, Karl Reinhard, et al.. (2019). Intra-arterial infusion chemotherapy versus isolated upper abdominal perfusion for advanced pancreatic cancer: a retrospective cohort study on 454 patients. Journal of Cancer Research and Clinical Oncology. 145(11). 2855–2862. 12 indexed citations
10.
Aigner, Karl Reinhard, et al.. (2018). Short-term intra-arterial infusion chemotherapy for head and neck cancer patients maintaining quality of life. Journal of Cancer Research and Clinical Oncology. 145(1). 261–268. 10 indexed citations
11.
Aigner, Kornelia, et al.. (1998). Regional versus systemic chemotherapy for advanced pancreatic cancer: a randomized study.. PubMed. 45(22). 1125–9. 34 indexed citations
12.
Vetter, N, David Stamler, Sean O’Neill, et al.. (1997). Clarithromycin vs Combined Cefuroxime and Erythromycin in the Treatment of Hospitalised Community-Acquired Pneumonia Patients - Intravenous Followed by Oral Therapy. Clinical Drug Investigation. 14(6). 439–449. 6 indexed citations
13.
Horikoshi, T., Kathleen D. Danenberg, Thomas Stadlbauer, et al.. (1992). Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction.. PubMed. 52(1). 108–16. 218 indexed citations
14.
Aigner, Kornelia, et al.. (1991). Mitomycin C in cancer chemotherapy today : selected proceedings of the 15th International Cancer Congress, Hamburg, Germany, August 16-22, 1990. 1 indexed citations
15.
Aigner, Kornelia, et al.. (1991). Celiac axis infusion (CAI) chemotherapy for advanced gastric cancer. Cancer treatment and research. 55. 357–362. 6 indexed citations
16.
Link, K. H., Dirk Kessler, & Kornelia Aigner. (1986). Dose response of mitoxantrone in cell lines and human solid tumor biopsies with first results in regional chemotherapy. Journal of Cancer Research and Clinical Oncology. 111(S1). S93–S93. 1 indexed citations
17.
Aigner, Kornelia, et al.. (1984). Augmentin in Acute Exacerbations of Chronic Bronchitis. Journal of International Medical Research. 12(6). 321–326. 7 indexed citations
18.
Breithaupt, H., et al.. (1982). Pharmacokinetics of dacarbazine (DTIC) and its metabolite 5-aminoimidazole-4-carboxamide (AIC) following different dose schedules. Cancer Chemotherapy and Pharmacology. 9(2). 103–109. 42 indexed citations
19.
Dobroschke, J., et al.. (1980). [Somatostatin in small intestine fistulas].. PubMed. 51(3). 155–7. 2 indexed citations
20.
Wewalka, G., et al.. (1979). [Legionnaires' disease in Austria].. PubMed. 121(42). 1349–50. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuji Bessho Breakdown of academic impact, for papers by Semyon A. Risin Breakdown of academic impact, for papers by K Csóka Breakdown of academic impact, for papers by Shinji Endo Breakdown of academic impact, for papers by Ashwini Esnakula Breakdown of academic impact, for papers by Satoshi Ohno Breakdown of academic impact, for papers by Robert L. Ruxer Breakdown of academic impact, for papers by D. Wouters Breakdown of academic impact, for papers by Kotaro Shibahara Breakdown of academic impact, for papers by C. Tolis
Rankless by CCL
2026